David Bregman, Md, Phd
AeroLeads people directory · profile

David Bregman, Md, Phd Email & Phone Number

Executive Medical Director, Pharmacovigilance and Risk Managment at Exelixis
Location: Bridgewater, New Jersey, United States 11 work roles 2 schools
1 work email found @sanofi.com 4 phones found area 908, 315, 207, and 610 LinkedIn matched
✓ Verified August 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email · 4 phones

Work email d****@sanofi.com
Direct phone (908) ***-****
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Executive Medical Director, Pharmacovigilance and Risk Managment
Location
Bridgewater, New Jersey, United States
Company size

Who is David Bregman, Md, Phd? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

David Bregman, Md, Phd is listed as Executive Medical Director, Pharmacovigilance and Risk Managment at Exelixis, a with 1499 employees, based in Bridgewater, New Jersey, United States. AeroLeads shows a work email signal at sanofi.com, phone signal with area code 908, 315, 207, 610, and a matched LinkedIn profile for David Bregman, Md, Phd.

David Bregman, Md, Phd previously worked as Therapeutic Area Strategy Lead, Pharmacovigilance /Oncology at Sanofi and Senior Global Safety Officer, Oncology at Sanofi. David Bregman, Md, Phd holds Residency In Pathology from Yale School Of Medicine.

Company email context

Email format at Exelixis

This section adds company-level context without repeating David Bregman, Md, Phd's masked contact details.

*@sanofi.com
68% confidence

AeroLeads found 1 current-domain work email signal for David Bregman, Md, Phd. Compare company email patterns before reaching out.

Profile bio

About David Bregman, Md, Phd

Pharmacovigilance strategy leader with biomedical (MD PhD) training and 25+ years’ experience in academia and pharmaceutical drug development. In my current position I guide a group of safety physicians and pharmacovigilance scientists who monitor and characterize the benefit / risk profiles of early to late development candidates in the therapeutic area of oncology. I have experience in the therapeutic areas of diabetes, lipid metabolism, kidney disease, and iron deficiency anemia.I also trained at Yale in Anatomic/Molecular Pathology and would love an opportunity that combines drug development with molecular tissue analysis.

Listed skills include Clinical Trials, Clinical Development, Diabetes, Pharmaceutical Industry, and 22 others.

Current workplace

David Bregman, Md, Phd's current company

Company context helps verify the profile and gives searchers a useful next step.

Exelixis
Exelixis
Executive Medical Director, Pharmacovigilance and Risk Managment
Bridgewater, NJ, US
Website
Employees
1499
AeroLeads page
11 roles · 31 years

David Bregman, Md, Phd work experience

A career timeline built from the work history available for this profile.

Executive Medical Director, Pharmacovigilance And Risk Managment

Bridgewater, Nj, Us

Therapeutic Area Strategy Lead, Pharmacovigilance /Oncology

Current

Paris, France, Fr

-Deputy to Therapeutic Area Head, PhV oncology-Promote harmonization of PhV activities across the oncology therapeutic area-Promote excellence in Benefits / Risk evaluation of oncology products-Train and mentor Global Safety Officers

May 2021 - Present

Senior Global Safety Officer, Oncology

Current

Paris, France, Fr

Nov 2019 - Present

Clinical Lead, Diabetes

Paris, France, Fr

Clinical Lead for Oral diabetes drug (sotagliflozin)Managed team including endocrinologists

Oct 2014 - Oct 2019

Senior Medical Director, Clinical Development

Danbury, Ct, Us

Pediatric program and Phase 4 investigations for Inhaled InsulinPresenter at Endocrine Metabolic Diabetes Advisory Committee meeting

May 2014 - Oct 2014

Medical Director, Clinical Development And Medical Affairs

Danbury, Ct, Us

Clinical lead for Phase 3 trial of Inhaled InsulinTeam Leader, Integrated Summary of Efficacy for NDA

Apr 2013 - Apr 2014

Senior Director, Clinical Development And Medical Affairs

Luitpold Pharmaceuticals

-Develop clinical strategy for drugs in development protocol design, interactions with FDA-Manage Medical Affairs for approved drugs phase 4 clinical trial design, thought leader interactions

Sep 2012 - Mar 2013

Medical Director

Luitpold Pharmaceuticals, Inc

Clinical Trial DesignDevelopmental Strategy DesignRegulatory Interactions with FDAMedical AffairsPharmacovigilance (backup)

Dec 2008 - Sep 2012

Clinical Research

Rahway, New Jersey, Us

Helped design a cardiovascular outcomes trial for a new diabetes drug

2007 - 2008 ~1 yr

Regulatory Affairs

Rahway, New Jersey, Us

Involved in early stage development for several lipid and diabetes drugs.

2002 - 2007 ~5 yrs

Associate Professor

Bronx, New York, Us

PI, small NIH funded research program investigating molecular mechanisms of celluar DNA damage response and implications for cancer treatments

1996 - 2002 ~6 yrs
Team & coworkers

Colleagues at Exelixis

Other employees you can reach at exelixis.com. View company contacts for 1499 employees →

2 education records

David Bregman, Md, Phd education

Residency In Pathology

Yale School Of Medicine

Md, Phd

Albert Einstein College Of Medicine
FAQ

Frequently asked questions about David Bregman, Md, Phd

Quick answers generated from the profile data available on this page.

What company does David Bregman, Md, Phd work for?

David Bregman, Md, Phd works for Exelixis.

What is David Bregman, Md, Phd's role at Exelixis?

David Bregman, Md, Phd is listed as Executive Medical Director, Pharmacovigilance and Risk Managment at Exelixis.

What is David Bregman, Md, Phd's email address?

AeroLeads has found 1 work email signal at @sanofi.com for David Bregman, Md, Phd at Exelixis.

What is David Bregman, Md, Phd's phone number?

AeroLeads has found 4 phone signal(s) with area code 908, 315, 207, 610 for David Bregman, Md, Phd at Exelixis.

Where is David Bregman, Md, Phd based?

David Bregman, Md, Phd is based in Bridgewater, New Jersey, United States while working with Exelixis.

What companies has David Bregman, Md, Phd worked for?

David Bregman, Md, Phd has worked for Exelixis, Sanofi, Mannkind Corporation, Luitpold Pharmaceuticals, and Luitpold Pharmaceuticals, Inc.

Who are David Bregman, Md, Phd's colleagues at Exelixis?

David Bregman, Md, Phd's colleagues at Exelixis include Ragadeepthi Tunduguru, Chi Tran, Cpa, Patricia Edwards, Palani Balu, and Xueqing Wen.

How can I contact David Bregman, Md, Phd?

You can use AeroLeads to view verified contact signals for David Bregman, Md, Phd at Exelixis, including work email, phone, and LinkedIn data when available.

What schools did David Bregman, Md, Phd attend?

David Bregman, Md, Phd holds Residency In Pathology from Yale School Of Medicine.

What skills is David Bregman, Md, Phd known for?

David Bregman, Md, Phd is listed with skills including Clinical Trials, Clinical Development, Diabetes, Pharmaceutical Industry, Medical Affairs, Pharmacovigilance, Fda, and Regulatory Affairs.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.